Client News
Medigene AG Reports Financial Results and Business Update for Q1 2024
26th April 2024
CARBIOS Celebrates the Groundbreaking of its PET Biorecycling Plant, a World First, with its Partners
25th April 2024
Affluent Medical: 2023 Financial Results and Update on Clinical Activities under Development
25th April 2024
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
25th April 2024
Medigene Presents Streamlined 6-Day, High Stemness TCR-T Therapy Production Process
25th April 2024
Formycon Reports Audited Annual Results for the Financial Year 2023 – Looking Back on a Successful Operative Year and Exceeded Guidance
25th April 2024
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
24th April 2024
TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare
24th April 2024
Medigene AG Launches Capital Increase with Subscription Rights and Backstop Agreement
23rd April 2024
Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB® to Enable Autologous Blood Transfusions in Cancer Surgeries
22nd April 2024
There is no more content to load